Creative Biolabs Accelerates Multiple Sclerosis Drug Discovery with Comprehensive EAE Animal Models
Creative Biolabs, a premier global contract research organization (CRO), has expanded its robust portfolio of Experimental Autoimmune Encephalomyelitis (EAE) models. Shirley, New York, United States, June 15, 2026 — As the global pharmaceutical industry accelerates… Read More »Creative Biolabs Accelerates Multiple Sclerosis Drug Discovery with Comprehensive EAE Animal Models





